Inactive Instrument

Hospira, Inc. Stock

Stocks

US4410601003

Pharmaceuticals

End-of-day quote NYSE
- ^USD	-

15-08-04	Hospira : Pfizer wins EU approval for $15 billion Hospira buy	RE
15-07-27	Allergan : Mylan independence from Teva's embrace comes with a price	RE

Latest news: Hospira, Inc.

15-08-04	Hospira : Pfizer wins EU approval for $15 billion Hospira buy	RE
15-07-27	Allergan : Mylan independence from Teva's embrace comes with a price	RE
15-07-14	Hospira : Pfizer offers concessions in bid to win EU okay for Hospira deal	RE
15-07-03	Celltrion : Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount	RE
15-05-06	Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal	RE
15-04-14	AbbVie : Banks see talent flee amid healthcare M&A boom	RE
15-04-08	Actavis : Generic drugmaker Mylan offers $29 billion for Perrigo	RE
15-03-05	AbbVie : boosts cancer drug pipeline with $21 billion Pharmacyclics deal	RE
15-03-05	AbbVie : Biotech buys get pharma M&A off to flying start in 2015	RE
15-03-05	AbbVie : boosts cancer drug pipeline with $21 billion Pharmacyclics deal	RE
15-02-25	Celltrion : Biosimilar copies of blockbuster drug launch in major EU markets	RE
15-02-05	Pfizer : to buy Hospira for $15 billion to bolster hospital products	RE
15-02-05	Hospira : Pfizer's Hospira deal bets on price spike for specialty generics	RE

Press Releases: Hospira, Inc.

15-08-27	Hospira : Announces First Installation of Plum 360™ Infusion System With Hospira MedNet™	PU
15-08-27	Hospira : Announces First Installation of Plum 360(TM) Infusion System With Hospira MedNet(TM)	PR
15-08-21	Hospira : Expert committee BACKS Hospira’s InflectraTM	PU
15-08-20	Hospira : Charleston Area Medical Center Integrates Smart Pump Technology to Advance Patient Safety	PR
15-08-19	Hospira : TGA Approves First mAb Biosimilar	PR

More press releases

News in other languages: Hospira, Inc.

15-08-27	Activision Blizzard et United Continental intègrent le S&P-500
15-08-24	Apple : Les valeurs à suivre à Wall Street
15-08-24	USA-Les valeurs à suivre à Wall Street
15-08-03	American : Les valeurs à suivre sur les marchés américains
15-08-03	USA-Les valeurs à suivre à Wall Street

Generic Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	ELI LILLY AND COMPANY	+6.64%	+5.18%	+68.94%	+142.95%	1,148B
	JOHNSON & JOHNSON	+1.22%	+3.11%	+47.88%	+87.68%	652B
	ABBVIE INC.	+1.65%	+1.74%	+28.88%	+104.49%	505B
	ROCHE HOLDING AG	+0.73%	+2.45%	+54.26%	+66.47%	384B
	MERCK & CO., INC.	+4.21%	-0.38%	+69.42%	+42.85%	348B
	NOVARTIS AG	+2.38%	+2.65%	+34.31%	+56.33%	294B
	ASTRAZENECA PLC	+2.26%	+0.55%	+3.92%	+27.74%	264B
	AMGEN INC.	+1.96%	+3.25%	+58.29%	+75.47%	244B
	GILEAD SCIENCES, INC.	+4.11%	+4.79%	+39.00%	+111.80%	197B
	Average	+2.84%	+1.39%	+44.99%	+79.53%	448.57B
	Weighted average by Cap.	+3.38%	+1.50%	+50.29%	+93.87%

See all sector performances

Company Profile

Employees

-

Sector

Pharmaceuticals

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

Maximize my profits

Maximize my profits

×